Proper Name: Influenza Virus Vaccine
Manufacturer: ID Biomedical Corporation of Quebec
- Active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLULAVAL is approved for use in persons 6 months of age and older.
- February 6, 2020 Approval Letter - FluLaval
- Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
- Statistical Review Assay - FluLaval and FluLaval Quadrivalent
- Clinical Review - FluLaval and FluLaval Quadrivalent
- Supporting Documents older than three years - FluLaval